唾液中黑激素水平的比较评估在患有牛症的患者:一个病例对照研究研究
Ceyda Gürhan1, Ercan Saruhan2, Ali Batuhan Bayırlı3
1Muğla Sıtkı Koçman University, Faculty of Dentistry, Department of Oral & Maxillofacial Radiology, Muğla, Turkey.
Biomarkers in medicine
|September 26, 2024
概括
这项研究发现,布鲁克斯症患者的夜间唾液黑激素水平较低. 压力和焦虑水平在布鲁克斯症和非布鲁克斯症组之间没有显著差异.
科学领域:
- 口腔医学是指口腔医学.
- 内分泌学 在内分泌学.
- 睡眠医学 睡眠医学
背景情况:
- 牙磨牙和牙的特征,通常与压力有关.
- 调节睡眠-清醒周期的荷尔蒙 - - 黑色素 (melatonin) 可能在布鲁克斯症病理生理学中起作用.
- 之前的研究已经探讨了心理因素和 Bruxism 之间的联系,但唾液中黑激素水平需要进一步调查.
研究的目的:
- 为了研究具有和没有 Bruxism 的个体之间的唾液黑激素水平的差异.
- 为了比较布鲁克斯症与非布鲁克斯症群体的压力和焦虑水平.
- 为了阐明黑激素分泌与 Bruxism 之间的关系.
主要方法:
- 符合可能的布鲁克斯症标准 (关于评估布鲁克斯症标准的国际共识) 的参与者组成了布鲁克斯症组.
- 唾液中的黑激素度使用ELISA套件量化.
- 为了评估压力和焦虑,进行了州道焦虑清单 (STAI).
主要成果:
- 与对照组相比,布鲁克西斯症组的夜间唾液黑激素水平显著降低 (p < 0.05).
- 在布鲁克斯症和对照组 (p > 0.05) 之间,没有观察到国家-海峡焦虑清单-海峡 (STAI-T) 评分的显著差异.
结论:
- 在减少的唾液黑激素水平和 Bruxism 之间存在显著的反向关系.
- Melatonin 缺乏可能是 Bruxism 的促成因素或生物标志物.
- 进一步的研究是有必要的,以探索针对黑激素通路的治疗干预措施,用于黑症管理.
相关概念视频
01:19Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
157
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
157